| Company Name: |
NCE Biomedical Co.,Ltd. |
| Tel: |
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 |
| Email: |
|
| Company Name: |
SPIRO PHARMA |
| Tel: |
|
| Email: |
eric_feng1954@126.com |
|
| | Mapatumumab Basic information |
| Product Name: | Mapatumumab | | Synonyms: | Mapatumumab;Research Grade Mapatumumab (DHA05901);Research Grade Mapatumumab;Mapatumumab (anti-TNFRSF10A) | | CAS: | 658052-09-6 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Mapatumumab Structure]() |
| | Mapatumumab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Mapatumumab Usage And Synthesis |
| Uses | Treatment
of cancer. | | in vivo | Mapatumumab (10 mg/kg; i.p. for three times) controls tumor growth when combined with irradiation[3]. | Animal Model: | Colo205-xenograft–bearing NMRI (nu/nu) nude mice[3] | | Dosage: | 10 mg/kg | | Administration: | Intraperitoneal injection; 10 mg/kg; on days 1, 4, and 8 | | Result: | Showed no significant differences when used alone, but when combined with irradiation (5×3 Gy, d1–5) showed a pronounced tumor regrowth-delay.
|
|
| | Mapatumumab Preparation Products And Raw materials |
|